Sangamo Therapeutics, Inc.
SGMO
$0.6532
$0.083114.58%
| Weiss Ratings | SGMO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | SGMO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | SGMO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 2.18 | |||
| Price History | SGMO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -24.92% | |||
| 30-Day Total Return | -40.62% | |||
| 60-Day Total Return | -49.75% | |||
| 90-Day Total Return | -66.67% | |||
| Year to Date Total Return | -42.19% | |||
| 1-Year Total Return | 12.35% | |||
| 2-Year Total Return | -62.24% | |||
| 3-Year Total Return | -89.48% | |||
| 5-Year Total Return | -90.35% | |||
| 52-Week High % Change | -82.07% | |||
| 52-Week Low % Change | 87.53% | |||
| Price | SGMO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $3.18 | |||
| 52-Week Low Price | $0.30 | |||
| 52-Week Low Price (Date) | Jul 05, 2024 | |||
| 52-Week High Price (Date) | Nov 08, 2024 | |||
| Valuation | SGMO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 128.11M | |||
| Enterprise Value | 116.76M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.52 | |||
| Earnings Per Share Growth | -64.61% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 2.07 | |||
| Price/Book (Q) | 5.33 | |||
| Enterprise Value/Revenue (TTM) | 2.02 | |||
| Price | $0.65 | |||
| Enterprise Value/EBITDA (TTM) | -1.25 | |||
| Enterprise Value/EBIT | -1.19 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | SGMO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 210.19M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | SGMO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 510 970 6000 | |||
| Address | 501 Canal Blvd Richmond, CA 94804 | |||
| Website | www.sangamo.com | |||
| Country | United States | |||
| Year Founded | 1995 | |||
| Profitability | SGMO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -170.15% | |||
| Profit Margin | -169.44% | |||
| Management Effectiveness | SGMO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -46.05% | |||
| Return on Equity | -- | |||
| Income Statement | SGMO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 57.80M | |||
| Total Revenue (TTM) | 57.80M | |||
| Revenue Per Share | $0.28 | |||
| Gross Profit (TTM) | -53.72M | |||
| EBITDA (TTM) | -93.24M | |||
| EBIT (TTM) | -98.35M | |||
| Net Income (TTM) | -97.94M | |||
| Net Income Avl. to Common (TTM) | -97.94M | |||
| Total Revenue Growth (Q YOY) | 269.78% | |||
| Earnings Growth (Q YOY) | 61.20% | |||
| EPS Diluted (TTM) | -0.52 | |||
| EPS Diluted Growth (Q YOY) | 65.86% | |||
| Balance Sheet | SGMO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 41.92M | |||
| Cash Per Share (Q) | $0.20 | |||
| Total Current Assets (Q) | 51.69M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 22.77M | |||
| Current Ratio (Q) | 1.129 | |||
| Book Value Per Share (Q) | $0.11 | |||
| Total Assets (Q) | 101.64M | |||
| Total Current Liabilities (Q) | 45.81M | |||
| Total Debt (Q) | 30.57M | |||
| Total Liabilities (Q) | 78.87M | |||
| Total Common Equity (Q) | 22.77M | |||
| Cash Flow | SGMO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 37.52M | |||
| Cash from Financing (TTM) | 28.38M | |||
| Net Change in Cash (TTM) | -3.29M | |||
| Levered Free Cash Flow (TTM) | -38.09M | |||
| Cash from Operations (TTM) | -67.14M | |||
